药明康德
(603259)
| 流通市值：3512.31亿 | | | 总市值：4309.87亿 |
| 流通股本：24.73亿 | | | 总股本：30.35亿 |
| 利润表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 营业总收入 | 45,537,430,834.54 | 28,897,478,718.36 | 12,435,776,568.29 | 45,456,165,774.18 |
| 营业总成本 | 25,611,145,432.57 | 16,254,491,694.29 | 7,433,446,073.33 | 29,148,154,763.35 |
| 其他经营收益 | | | | |
| 营业利润 | 24,070,465,877.48 | 13,530,327,993.62 | 5,614,936,555.19 | 23,930,083,791.6 |
| 利润总额 | 24,049,490,430.72 | 13,517,559,065.27 | 5,607,280,256.21 | 23,906,151,246.45 |
| 净利润 | 19,505,422,816.08 | 11,126,333,943.9 | 4,670,513,981.33 | 19,333,065,892.26 |
| 每股收益 | | | | |
| 其他综合收益 | -936,050,415.72 | -514,298,277.29 | -273,737,529.63 | -449,776,946.3 |
| 综合收益总额 | 18,569,372,400.36 | 10,612,035,666.61 | 4,396,776,451.7 | 18,883,288,945.96 |
| 资产负债表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 流动资产: | | | | |
| 流动资产合计 | 81,788,465,846.72 | 73,147,205,804.57 | 65,169,309,017.78 | 61,677,055,890.49 |
| 非流动资产: | | | | |
| 非流动资产合计 | 43,367,071,333.08 | 43,115,345,694.71 | 42,245,172,323.47 | 41,443,912,688.62 |
| 资产总计 | 125,155,537,179.8 | 116,262,551,499.28 | 107,414,481,341.25 | 103,120,968,579.11 |
| 流动负债: | | | | |
| 流动负债合计 | 23,852,580,880.4 | 28,794,593,339.95 | 19,041,485,532.7 | 19,235,268,205.24 |
| 非流动负债: | | | | |
| 非流动负债合计 | 3,848,958,078.07 | 3,583,962,879.87 | 3,601,366,399.65 | 3,637,986,772.35 |
| 负债合计 | 27,701,538,958.47 | 32,378,556,219.82 | 22,642,851,932.35 | 22,873,254,977.59 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 96,845,248,979.81 | 83,333,717,174.75 | 84,221,755,533.76 | 79,712,290,246.44 |
| 股东权益合计 | 97,453,998,221.33 | 83,883,995,279.46 | 84,771,629,408.9 | 80,247,713,601.52 |
| 负债和股东权益合计 | 125,155,537,179.8 | 116,262,551,499.28 | 107,414,481,341.25 | 103,120,968,579.11 |
| 现金流量表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 48,929,111,252.51 | 29,836,617,527.32 | 13,560,976,178.65 | 51,752,563,331.28 |
| 经营活动现金流出小计 | 31,735,955,529.22 | 20,137,475,139.24 | 9,965,165,852.12 | 34,549,401,709.28 |
| 经营活动产生的现金流量净额 | 17,193,155,723.29 | 9,699,142,388.08 | 3,595,810,326.53 | 17,203,161,622 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 23,791,865,534.21 | 13,808,539,667.91 | 3,818,368,757.52 | 24,467,836,005.76 |
| 投资活动现金流出小计 | 37,683,855,808.43 | 24,665,028,955.54 | 9,166,737,566.81 | 26,412,945,914.64 |
| 投资活动产生的现金流量净额 | -13,891,990,274.22 | -10,856,489,287.63 | -5,348,368,809.29 | -1,945,109,908.88 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 16,002,965,423.2 | 12,715,361,895.41 | 3,377,302,944.51 | 21,137,042,474.82 |
| 筹资活动现金流出小计 | 18,484,481,140.7 | 13,614,672,370.32 | 3,452,282,426.88 | 20,013,501,429.36 |
| 筹资活动产生的现金流量净额 | -2,481,515,717.5 | -899,310,474.91 | -74,979,482.37 | 1,123,541,045.46 |
| 汇率变动对现金及现金等价物的影响 | -749,382,157.27 | -445,588,979.92 | -198,774,624.87 | -370,473,427.27 |
| 现金及现金等价物净增加额 | 70,267,574.3 | -2,502,246,354.38 | -2,026,312,590 | 16,011,119,331.31 |
| 期末现金及现金等价物余额 | 29,526,098,123.25 | 26,953,584,194.57 | 27,429,517,958.95 | 29,455,830,548.95 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | - | -2,502,246,354.38 | - | 16,011,119,331.31 |
最新报告期：2026-10-29| 研究机构 | 分析师 | 预测每股收益(元) | 更新日 |
| 2026年 | 2027年 | 2028年 |
| 招商证券 | 梁广楷,许菲菲 | 8.03 | 9.47 | 11.02 | 2026-10-29 |
| 华西证券 | 崔文亮,徐顺利 | 8.56 | 10.39 | 12.31 | 2026-10-28 |
| 开源证券 | 余汝意 | 8.37 | 9.91 | 12.56 | 2026-10-28 |
| 华泰证券 | 代雯,李奕玮 | 8.36 | 9.67 | 11.28 | 2026-10-27 |
| 湘财证券 | 蒋栋 | 8.17 | 9.04 | 11.01 | 2026-10-27 |